Literature DB >> 9199340

CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites.

V S Shapiro1, K E Truitt, J B Imboden, A Weiss.   

Abstract

Mutagenesis studies have demonstrated the requirement for the CD28-responsive element (CD28RE) within the interleukin-2 (IL-2) promoter for transcriptional upregulation by CD28. Here, we demonstrate that CD28 responsiveness is conferred by a composite element containing both the CD28RE and the NF-IL-2B AP-1 sites (RE/AP). Mutations at either site within the RE/AP composite element abolish activity. The RE/AP composite element is a site for signal integration within the IL-2 promoter, since its activation is dependent on at least two separate signalling pathways being activated, through the T-cell receptor, CD28, and/or phorbol myristate acetate. Activation is maximal when all three signals occur simultaneously. By using a panel of CD28 cytoplasmic domain mutants, it was found that the transcriptional activation of the RE/AP composite element correlates exactly with the pattern of IL-2 secretion induced by these mutants upon stimulation. Similar to the upregulation of IL-2 secretion, the transcriptional upregulation of the RE/AP composite element by CD28 is FK506 insensitive. The pattern of activation of the RE/AP composite element is different from that observed for either an NFAT or consensus AP-1 site, implying that RE/AP represents a unique element. Using gel shift analysis, we demonstrate that stimulation by CD28 induces the association of the NF-kappaB family member c-Rel to the CD28RE within the RE/AP composite element. The transcriptional upregulation of IL-2 by CD28 appears, therefore, to be mediated through the RE/AP composite element, involving the association of c-Rel with the CD28RE.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9199340      PMCID: PMC232258          DOI: 10.1128/MCB.17.7.4051

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  34 in total

Review 1.  The ups and downs of T cell costimulation.

Authors:  M K Jenkins
Journal:  Immunity       Date:  1994-09       Impact factor: 31.745

Review 2.  The architecture of the interleukin-2 promoter: a reflection of T lymphocyte activation.

Authors:  E Serfling; A Avots; M Neumann
Journal:  Biochim Biophys Acta       Date:  1995-09-19

3.  Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression.

Authors:  F Köntgen; R J Grumont; A Strasser; D Metcalf; R Li; D Tarlinton; S Gerondakis
Journal:  Genes Dev       Date:  1995-08-15       Impact factor: 11.361

4.  JNK is involved in signal integration during costimulation of T lymphocytes.

Authors:  B Su; E Jacinto; M Hibi; T Kallunki; M Karin; Y Ben-Neriah
Journal:  Cell       Date:  1994-06-03       Impact factor: 41.582

5.  Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses.

Authors:  W C Sha; H C Liou; E I Tuomanen; D Baltimore
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

6.  Activation of IL-2 receptor alpha-chain gene by individual members of the rel oncogene family in association with serum response factor.

Authors:  J W Pierce; C A Jamieson; J L Ross; R Sen
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

7.  RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter.

Authors:  J H Lai; G Horvath; J Subleski; J Bruder; P Ghosh; T H Tan
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

Review 8.  T cell anergy.

Authors:  J M LaSalle; D A Hafler
Journal:  FASEB J       Date:  1994-06       Impact factor: 5.191

Review 9.  The B7 and CD28 receptor families.

Authors:  C H June; J A Bluestone; L M Nadler; C B Thompson
Journal:  Immunol Today       Date:  1994-07

10.  AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes.

Authors:  M Rincón; R A Flavell
Journal:  EMBO J       Date:  1994-09-15       Impact factor: 11.598

View more
  67 in total

Review 1.  Selectivity of the NF-{kappa}B response.

Authors:  Ranjan Sen; Stephen T Smale
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10-14       Impact factor: 10.005

2.  Pleiotropic contributions of phospholipase C-gamma1 (PLC-gamma1) to T-cell antigen receptor-mediated signaling: reconstitution studies of a PLC-gamma1-deficient Jurkat T-cell line.

Authors:  B J Irvin; B L Williams; A E Nilson; H O Maynor; R T Abraham
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 3.  Genetic analysis of CD28 signaling.

Authors:  Tiffani A Greene; Virginia Smith Shapiro
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

4.  Expression and function of Tec, Itk, and Btk in lymphocytes: evidence for a unique role for Tec.

Authors:  Michael G Tomlinson; Lawrence P Kane; Jennifer Su; Theresa A Kadlecek; Marianne N Mollenauer; Arthur Weiss
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

5.  Kinase control prevents HIV-1 reactivation in spite of high levels of induced NF-κB activity.

Authors:  Frank Wolschendorf; Alberto Bosque; Takao Shishido; Alexandra Duverger; Jennifer Jones; Vicente Planelles; Olaf Kutsch
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

Review 6.  An enigmatic tail of CD28 signaling.

Authors:  Jonathan S Boomer; Jonathan M Green
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-09       Impact factor: 10.005

7.  CARMA1 is required for Akt-mediated NF-kappaB activation in T cells.

Authors:  Preeti Narayan; Brittany Holt; Richard Tosti; Lawrence P Kane
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

8.  Phosphorylation at serine 318 is not required for inhibition of T cell activation by ALX.

Authors:  Michael J Shapiro; Lynn Spruce; Rhianna Sundsbak; Puspa Thapa; Virginia Smith Shapiro
Journal:  Biochem Biophys Res Commun       Date:  2010-05-13       Impact factor: 3.575

Review 9.  CD28 Costimulation: From Mechanism to Therapy.

Authors:  Jonathan H Esensten; Ynes A Helou; Gaurav Chopra; Arthur Weiss; Jeffrey A Bluestone
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

10.  Negative regulation of TCR signaling by linker for activation of X cells via phosphotyrosine-dependent and -independent mechanisms.

Authors:  Michael J Shapiro; Chau T Nguyen; Haig Aghajanian; Weiguo Zhang; Virginia Smith Shapiro
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.